Assessment of clinical outcomes of isolation and diagnoses related to bacteria caused by pregnant women with urinary tract infections in Wasit Governorate
Keywords:
Urinary tract infection (UTI), pregnant women, Escherichia coli, pregnancy, Proteus mirabilis, bacterialAbstract
Urinary tract infection (UTI) is one of the most prevalent bacterial infections that can occur during pregnancy that can be harmful to both the mother and the unborn child. The present study aimed to isolate and identify the bacterial species responsible for UTI's among pregnant women and their susceptibility pattern to antimicrobials and risk factors associated with them.
To find and isolate bacteria that cause urinary tract infections (UTIs) in pregnant women, evaluate patterns of antibiotic susceptibility, and pinpoint risk factors for UTIs, a cross-sectional study was carried out. Fifteen of them were clinically suspected to have a UTI and were asked to participate in the study and were enrolled into the study. Using the calibrated loop technique, a clean catch midstream urine was obtained and grown on MacConkey and cystine lactose electrolyte deficiency agars.
The results showed that Escherichia coli was the most common isolate, followed by Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecalis, Staphylococcus saprophyticus, Group B Streptococcus, Pseudomonas aeruginosa, and coagulase-negative staphylococci. The third trimester had the highest prevalence of UTI. In vitro activity of the drugs to the majority of isolates was highest for nitrofurantoin and fosfomycin, and lowest for ampicillin and amoxicillin.
The present study has found that Escherichia coli is still the leading causative organism for UTI in pregnant women, followed by Klebsiella pneumoniae, Proteus mirabilis, and Enterococcus faecalis. The prevalence of UTI rises with age of pregnancy, being the highest in the third trimester. Nitrofurantoin and fosfomycin have excellent in vitro activity against most uropathogens and are suitable first-line drugs for UTI in pregnancy, while high resistance rates to ampicillin and amoxicillin mean that they cannot be used as first-line options. The most important independent risk factors are previous UTI, urinary catheterization, and diabetes mellitus. The most common isolates were Escherichia coli, followed by Group B Streptococcus, Pseudomonas aeruginosa, Proteus mirabilis, Enterococcus faecalis, Staphylococcus saprophyticus, Klebsiella pneumoniae, and coagulase-negative staphylococci. Third trimester was most common for the development of UTI.
Lastly, the current study discovered that Enterococcus faecalis, Proteus mirabilis, Klebsiella pneumoniae, and Escherichia coli continue to be the most common cause of UTIs in pregnant women. UTIs are more prevalent with pregnancy, with the highest prevalence in the third trimester. Ampicillin/amoxicillin is not considered as initial treatment because of high resistance rates, and nitrofurantoin and fosfomycin have good in vitro activity and can be used as first choice for UTI in pregnancy.